This protocol is not appropriate with active or recent cancer or with pituitary disease, and it may affect glucose tolerance, which matters if you have diabetes or pre-diabetic markers
Reported risks and adverse effects associated with intravenous glutathione administration include the following: Injection site reactions: Bruising, pain, or swelling at the cannula insertion site are among the most commonly reported effects
Compounded tirzepatide formulations, including those with B12, present distinct safety considerations that differ from FDA-approved products
How do you reduce high B12 levels
Jumping to the full dose immediately would produce severe nausea and vomiting in most people
Glutathione is known as a master oxidant and is composed of three amino acids glycine, cysteine, and glutamic acid